Moderna’s mRNA Flu Vaccine Back Under FDA Review

THURSDAY, Feb. 19, 2026 (HealthDay News) — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine. 

The move comes just one week after the agency refused to evaluate the company’s application, a decision that sent shockwaves through the biotech industry.

The initial rejection centered on the design of Moderna’s clinical trials. 

Regulators had previously argued that the company should have tested its shot against a higher-strength flu vaccine for the older adults in the trial’s control group. 

Following the rejection, Moderna modified its approach to satisfy the government’s concerns.

Full Article

Allergy Information

What Are Seasonal Allergies?

More than 67 million americans suffer from allergy symptoms, including hay fever. But, what is an allergy? What is an allergic reaction? What are common allergy symptoms? What allergy treatments are available?

Full Article

What is Pollen?

Pollen is one of the most common allergens in the United States. Pollen is an airborne allergen, which is picked up and carried by the wind. Various trees, grasses and weeds create pollen, which can cause hay fever, irritate your eyes and skin.

Full Article